vs

Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and IT TECH PACKAGING, INC. (ITP). Click either name above to swap in a different company.

AbCellera Biologics Inc. is the larger business by last-quarter revenue ($44.9M vs $25.6M, roughly 1.8× IT TECH PACKAGING, INC.). IT TECH PACKAGING, INC. runs the higher net margin — -5.7% vs -19.9%, a 14.3% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 2.1%). IT TECH PACKAGING, INC. produced more free cash flow last quarter ($1.5M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 10.5%).

AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.

IT TECH PACKAGING, INC. is a paper manufacturing enterprise primarily operating in China. It produces and distributes a diverse portfolio of paper products including corrugated packaging paper, boxboard, and printing-use cultural paper, serving sectors such as consumer goods packaging, logistics, and commercial printing across its core market.

ABCL vs ITP — Head-to-Head

Bigger by revenue
ABCL
ABCL
1.8× larger
ABCL
$44.9M
$25.6M
ITP
Growing faster (revenue YoY)
ABCL
ABCL
+786.3% gap
ABCL
788.4%
2.1%
ITP
Higher net margin
ITP
ITP
14.3% more per $
ITP
-5.7%
-19.9%
ABCL
More free cash flow
ITP
ITP
$46.1M more FCF
ITP
$1.5M
$-44.6M
ABCL
Faster 2-yr revenue CAGR
ABCL
ABCL
Annualised
ABCL
112.3%
10.5%
ITP

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
ABCL
ABCL
ITP
ITP
Revenue
$44.9M
$25.6M
Net Profit
$-8.9M
$-1.4M
Gross Margin
7.9%
Operating Margin
-63.7%
-3.9%
Net Margin
-19.9%
-5.7%
Revenue YoY
788.4%
2.1%
Net Profit YoY
73.9%
26.6%
EPS (diluted)
$-0.03
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABCL
ABCL
ITP
ITP
Q4 25
$44.9M
Q3 25
$9.0M
$25.6M
Q2 25
$17.1M
$24.8M
Q1 25
$4.2M
$10.9M
Q4 24
$5.0M
$17.6M
Q3 24
$6.5M
$25.1M
Q2 24
$7.3M
$26.2M
Q1 24
$10.0M
$6.9M
Net Profit
ABCL
ABCL
ITP
ITP
Q4 25
$-8.9M
Q3 25
$-57.1M
$-1.4M
Q2 25
$-34.7M
$-2.0M
Q1 25
$-45.6M
$-3.5M
Q4 24
$-4.0M
Q3 24
$-51.1M
$-2.0M
Q2 24
$-36.9M
$-77.7K
Q1 24
$-40.6M
$-3.7M
Gross Margin
ABCL
ABCL
ITP
ITP
Q4 25
Q3 25
7.9%
Q2 25
5.1%
Q1 25
0.8%
Q4 24
6.3%
Q3 24
7.6%
Q2 24
12.4%
Q1 24
5.8%
Operating Margin
ABCL
ABCL
ITP
ITP
Q4 25
-63.7%
Q3 25
-851.8%
-3.9%
Q2 25
-290.2%
-7.1%
Q1 25
-1479.6%
-31.0%
Q4 24
-21.5%
Q3 24
-1439.4%
-5.8%
Q2 24
-1276.2%
2.1%
Q1 24
-551.5%
-51.0%
Net Margin
ABCL
ABCL
ITP
ITP
Q4 25
-19.9%
Q3 25
-637.8%
-5.7%
Q2 25
-203.3%
-7.9%
Q1 25
-1077.2%
-32.2%
Q4 24
-22.9%
Q3 24
-785.4%
-7.9%
Q2 24
-504.3%
-0.3%
Q1 24
-408.0%
-54.6%
EPS (diluted)
ABCL
ABCL
ITP
ITP
Q4 25
$-0.03
Q3 25
$-0.19
$-0.11
Q2 25
$-0.12
$-0.16
Q1 25
$-0.15
$-0.35
Q4 24
$-0.40
Q3 24
$-0.17
$-0.20
Q2 24
$-0.13
$-0.01
Q1 24
$-0.14
$-0.37

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABCL
ABCL
ITP
ITP
Cash + ST InvestmentsLiquidity on hand
$128.5M
Total DebtLower is stronger
$4.7M
Stockholders' EquityBook value
$966.9M
$152.0M
Total Assets
$1.4B
$175.7M
Debt / EquityLower = less leverage
0.03×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABCL
ABCL
ITP
ITP
Q4 25
$128.5M
Q3 25
$83.2M
Q2 25
$92.4M
Q1 25
$159.3M
Q4 24
$156.3M
Q3 24
$126.6M
Q2 24
$148.3M
Q1 24
$123.6M
Total Debt
ABCL
ABCL
ITP
ITP
Q4 25
Q3 25
$4.7M
Q2 25
$4.7M
Q1 25
$4.7M
Q4 24
$4.7M
Q3 24
$8.9M
Q2 24
$11.3M
Q1 24
$11.4M
Stockholders' Equity
ABCL
ABCL
ITP
ITP
Q4 25
$966.9M
Q3 25
$964.0M
$152.0M
Q2 25
$1.0B
$152.3M
Q1 25
$1.0B
$152.8M
Q4 24
$1.1B
$156.1M
Q3 24
$1.1B
$164.3M
Q2 24
$1.1B
$163.5M
Q1 24
$1.1B
$164.3M
Total Assets
ABCL
ABCL
ITP
ITP
Q4 25
$1.4B
Q3 25
$1.4B
$175.7M
Q2 25
$1.4B
$175.2M
Q1 25
$1.3B
$175.2M
Q4 24
$1.4B
$177.5M
Q3 24
$1.4B
$190.0M
Q2 24
$1.4B
$191.4M
Q1 24
$1.5B
$177.5M
Debt / Equity
ABCL
ABCL
ITP
ITP
Q4 25
Q3 25
0.03×
Q2 25
0.03×
Q1 25
0.03×
Q4 24
0.03×
Q3 24
0.05×
Q2 24
0.07×
Q1 24
0.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABCL
ABCL
ITP
ITP
Operating Cash FlowLast quarter
$-34.7M
$1.5M
Free Cash FlowOCF − Capex
$-44.6M
$1.5M
FCF MarginFCF / Revenue
-99.4%
5.9%
Capex IntensityCapex / Revenue
21.9%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-174.1M
$3.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABCL
ABCL
ITP
ITP
Q4 25
$-34.7M
Q3 25
$-52.6M
$1.5M
Q2 25
$-32.4M
$1.4M
Q1 25
$-11.6M
$-2.5M
Q4 24
$-108.6M
$3.5M
Q3 24
$-28.9M
$1.5M
Q2 24
$-30.0M
$721.9K
Q1 24
$-41.7M
$624.4K
Free Cash Flow
ABCL
ABCL
ITP
ITP
Q4 25
$-44.6M
Q3 25
$-61.5M
$1.5M
Q2 25
$-45.8M
$1.3M
Q1 25
$-22.2M
$-2.5M
Q4 24
$-187.0M
$3.5M
Q3 24
$-47.4M
$1.2M
Q2 24
$-50.1M
$668.3K
Q1 24
$-65.8M
$615.4K
FCF Margin
ABCL
ABCL
ITP
ITP
Q4 25
-99.4%
Q3 25
-687.0%
5.9%
Q2 25
-267.9%
5.4%
Q1 25
-524.0%
-22.8%
Q4 24
-3702.8%
19.6%
Q3 24
-728.4%
4.9%
Q2 24
-683.8%
2.5%
Q1 24
-661.5%
9.0%
Capex Intensity
ABCL
ABCL
ITP
ITP
Q4 25
21.9%
Q3 25
99.7%
0.0%
Q2 25
78.2%
0.1%
Q1 25
251.1%
0.1%
Q4 24
1552.7%
0.1%
Q3 24
284.6%
1.0%
Q2 24
274.6%
0.2%
Q1 24
242.5%
0.1%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons